Centene (CNC) Projected to Post Earnings on Wednesday

Centene (NYSE:CNC) is expected to release its Q3 2025 results before the market opens on Wednesday, October 29th. Analysts expect Centene to post earnings of ($0.18) per share and revenue of $47.5021 billion for the quarter. Interested persons can find conference call details on the company’s upcoming Q3 2025 earningreport page for the latest details on the call scheduled for Wednesday, October 29, 2025 at 9:00 AM ET.

Centene (NYSE:CNC) last issued its quarterly earnings results on Friday, July 25th. The company reported ($0.16) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.23 by ($0.39). Centene had a net margin of 1.15% and a return on equity of 9.57%. The company had revenue of $48.74 billion for the quarter, compared to analyst estimates of $44.71 billion. During the same quarter in the previous year, the company posted $2.42 EPS. The company’s revenue for the quarter was up 22.4% compared to the same quarter last year. On average, analysts expect Centene to post $7 EPS for the current fiscal year and $7 EPS for the next fiscal year.

Centene Trading Down 3.0%

Shares of Centene stock opened at $33.06 on Tuesday. The company has a current ratio of 1.10, a quick ratio of 1.10 and a debt-to-equity ratio of 0.64. Centene has a 12-month low of $25.08 and a 12-month high of $66.81. The firm has a market capitalization of $16.24 billion, a price-to-earnings ratio of 8.18, a PEG ratio of 1.34 and a beta of 0.48. The firm’s 50 day simple moving average is $33.09 and its two-hundred day simple moving average is $42.35.

Analysts Set New Price Targets

A number of research firms have recently weighed in on CNC. JPMorgan Chase & Co. cut their price objective on shares of Centene from $48.00 to $30.00 and set a “neutral” rating on the stock in a research note on Tuesday, July 29th. TD Cowen reiterated a “hold” rating and issued a $33.00 price objective (down previously from $73.00) on shares of Centene in a research note on Monday, July 21st. Bank of America lowered shares of Centene from a “neutral” rating to an “underperform” rating and cut their price objective for the stock from $52.00 to $30.00 in a research note on Wednesday, July 16th. Wells Fargo & Company set a $41.00 price objective on shares of Centene and gave the stock an “equal weight” rating in a research note on Tuesday, October 7th. Finally, The Goldman Sachs Group initiated coverage on shares of Centene in a research note on Tuesday, October 14th. They issued a “sell” rating and a $33.00 price objective on the stock. Three investment analysts have rated the stock with a Buy rating, thirteen have issued a Hold rating and three have issued a Sell rating to the stock. Based on data from MarketBeat.com, Centene has a consensus rating of “Hold” and an average target price of $39.50.

Insider Transactions at Centene

In related news, CEO Sarah London acquired 19,230 shares of the firm’s stock in a transaction on Friday, August 8th. The shares were acquired at an average cost of $25.50 per share, with a total value of $490,365.00. Following the completion of the acquisition, the chief executive officer directly owned 845,275 shares in the company, valued at approximately $21,554,512.50. This trade represents a 2.33% increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Company insiders own 0.36% of the company’s stock.

Hedge Funds Weigh In On Centene

Several hedge funds and other institutional investors have recently added to or reduced their stakes in CNC. Baird Financial Group Inc. purchased a new position in Centene during the first quarter valued at $236,000. Sivia Capital Partners LLC lifted its holdings in Centene by 80.0% during the second quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock valued at $527,000 after purchasing an additional 4,315 shares in the last quarter. CW Advisors LLC raised its position in shares of Centene by 20.3% in the second quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock valued at $264,000 after buying an additional 820 shares during the last quarter. NewEdge Advisors LLC raised its position in shares of Centene by 6.1% in the second quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock valued at $2,440,000 after buying an additional 2,582 shares during the last quarter. Finally, Treasurer of the State of North Carolina raised its position in shares of Centene by 0.4% in the second quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock valued at $12,590,000 after buying an additional 967 shares during the last quarter. 93.63% of the stock is owned by hedge funds and other institutional investors.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.